Cancer Institute A national cancer institute
designated cancer center
Email this profile
Portrait View Larger

Clare J. Twist

Academic Appointments

  • Associate Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital

Key Documents

Contact Information

  • Clinical Offices
    Pediatric Hematology-Oncology 725 Welch Rd MC 5798 Palo Alto, CA 94304
    Tel Work (650) 497-8953 Fax (650) 497-8959
  • Academic Offices
    Personal Information
    Email Tel (650) 723-5535
    Alternate Contact
    Stephanie Colombo Administrative Assistant Tel Work 6507235535
    Not for medical emergencies or patient use


Clinical Focus

  • Hematology/Oncology/Stem Cell Transplant, Pediatric
  • Oncology (Cancer), Pediatric
  • Pediatric Hematology-Oncology

Academic Appointments

Professional Education

Internship: Children's Memorial Hospital IL (1988)
Residency: Children's Memorial Hospital IL (1990)
Fellowship: Children's Hospital Boston MA (1993)
Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1994)
Medical Education: Albany Medical Center NY (1987)
Fellowship: Children's Hospital, Boston/DFCI, Pediatric Hematology & Oncology (1993)
View All 10

Research & Scholarship

Current Research and Scholarly Interests

My primary research interest is in the study and treatment of neuroblastoma. My clinical interests also include Wilms tumor, hepatoblastoma, post-transplant lymphoproliferative disorders, phase I therapies for hematologic malignancies, as well as palliative and end of life care.

As a clinical investigator in the Children's Oncology Group (COG), I am involved in the clinical trial design of treatment protocols for patients with neuroblastoma, and am the Study Chair for the current COG Phase III Study for the treatment of children with Intermediate Risk Neuroblastoma. I am also the Principal Investigator at Stanford for the New Advances in Neuroblastoma (NANT) Consortium, a limited institution consortium which develops Phase I trials of novel therapies for patients with high risk and recurrent neuroblastoma. I am also interested in new therapies for the treatment of hematologic malignancies and am the Principal Investigator at Stanford for the Therapeutic Advances in Childhood Leukemia (TACL) Consortium, another limited institution consortium specifically dedicated to the development of novel therapies for relapsed leukemias.






Publication tag cloud

Publication Topics

View All 19

Stanford Medicine Resources:

Footer Links: